Hold Rating on Healthcare Services Group Amidst Revenue Stability and Industry Uncertainties
TipRanksApr 26 14:00
Baird Adjusts Price Target on Healthcare Services Group to $13 From $10, Maintains Neutral Rating
MT NewswiresFeb 16 00:16
RBC Capital Maintains Outperform on Healthcare Services Group, Raises Price Target to $15
BenzingaFeb 15 23:21
Healthcare Services Group Analyst Ratings
BenzingaFeb 15 23:19
Benchmark Reiterates Buy on Healthcare Services Group, Maintains $16 Price Target
BenzingaDec 22, 2023 23:59
Healthcare Services Group Analyst Ratings
BenzingaDec 22, 2023 23:58
UBS Initiates Coverage on Healthcare Services Group With Neutral Rating, $11 Price Target
MT NewswiresDec 1, 2023 01:37
UBS Initiates Coverage On Healthcare Services Group With Neutral Rating, Announces Price Target of $11
BenzingaNov 30, 2023 17:57
Healthcare Services Group Analyst Ratings
BenzingaNov 30, 2023 17:55
Benchmark Maintains Buy on Healthcare Services Group, Lowers Price Target to $16
BenzingaOct 27, 2023 00:23
Healthcare Services Group Analyst Ratings
BenzingaOct 27, 2023 00:22
RBC Cuts Price Target on Healthcare Services Group to $14 From $16, Keeps Outperform Rating
MT NewswiresOct 26, 2023 20:02
Benchmark Reiterates Buy on Healthcare Services Group, Maintains $18 Price Target
BenzingaAug 31, 2023 20:44
Healthcare Services Group Analyst Ratings
BenzingaAug 31, 2023 20:43
RBC Capital Reiterates Outperform on Healthcare Services Group, Maintains $16 Price Target
BenzingaAug 1, 2023 21:10
Healthcare Services Group Analyst Ratings
BenzingaAug 1, 2023 21:09
RBC Capital Maintains Outperform on Healthcare Services Group, Lowers Price Target to $16
BenzingaJul 27, 2023 23:49
Healthcare Services Group Analyst Ratings
BenzingaJul 27, 2023 23:48
Credit Suisse Maintains Neutral on Healthcare Services Group, Raises Price Target to $17
BenzingaApr 28, 2023 20:40
RBC Capital Reiterates Outperform on Healthcare Services Group, Maintains $17 Price Target
BenzingaApr 27, 2023 21:15
No Data
No Data